相关实验视频

Updated: Sep 12, 2025

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

在 Beta-thalassemia 中介与罕见突变中对基尿素的治疗反应:一个病例报告

Hassan Fawaz¹, Mohammad Hassan Hodroj¹, Nicole Charbel¹

¹Division of Hematology & Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

|August 7, 2025

概括

在一个β-thalassemia中介患者中,发现了一种罕见的beta-globin基因促进体 (HBB:c.-136C>G) 的同卵性突变. 基尿素疗法显著改善了血红蛋白水平并减少了症状,证明了其针对个性化治疗的潜力.

科学领域:

血液学血液学血液学
遗传学是一个遗传学.
药理学药理学是指药理学的学科.

背景情况:

由于基因突变,β-thalassemia具有不同的临床表现.
了解罕见的遗传变异对于有效的疾病管理至关重要.

研究的目的:

报告一种罕见的同卵性促进体突变的β-thalassemia中间体病例.
为了评估基尿素治疗在这个患者的疗效.

主要方法:

基因测序以确定HBB基因突变.
临床评估患者对基尿素治疗的反应.

主要成果:

在β-环球蛋白基因促进体中发现了一种同卵性HBB:c.-136C>G突变.
观察到血红蛋白水平的显著改善,并减少了与氧尿素的外骨质造血症症状.

结论:

遗传特征对于理解罕见的β-thalassemia形式至关重要.
氧尿素显示出作为个性化治疗独特遗传特征患者的承诺.

关键词:

氧尿素可以在水中形成.贝塔沙拉西米亚贝塔沙拉西米亚贝塔 - thalassemia中介性的中间体.

更多相关视频

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...